Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Change in Inventory (2021 - 2025)

Historic Change in Inventory for Evogene (EVGN) over the last 5 years, with Q3 2025 value amounting to -$139000.0.

  • Evogene's Change in Inventory rose 7922.27% to -$139000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$989000.0, marking a year-over-year increase of 3079.08%. This contributed to the annual value of -$1.3 million for FY2024, which is 36061.22% down from last year.
  • Evogene's Change in Inventory amounted to -$139000.0 in Q3 2025, which was up 7922.27% from -$154000.0 recorded in Q2 2025.
  • Over the past 5 years, Evogene's Change in Inventory peaked at $342000.0 during Q2 2023, and registered a low of -$669000.0 during Q3 2024.
  • Moreover, its 5-year median value for Change in Inventory was -$115500.0 (2021), whereas its average is -$158187.5.
  • In the last 5 years, Evogene's Change in Inventory soared by 463333.33% in 2023 and then crashed by 246000.0% in 2024.
  • Evogene's Change in Inventory (Quarter) stood at -$92000.0 in 2021, then plummeted by 335.87% to -$401000.0 in 2022, then soared by 109.23% to $37000.0 in 2023, then crashed by 1081.08% to -$363000.0 in 2024, then surged by 61.71% to -$139000.0 in 2025.
  • Its last three reported values are -$139000.0 in Q3 2025, -$154000.0 for Q2 2025, and -$333000.0 during Q1 2025.